Malignant neoplasm of overlapping sites of connective and soft tissue
- C49.8 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- Short description: Malignant neoplasm of ovrlp sites of conn and soft tissue
- The 2024 edition of ICD-10-CM C49.8 became effective on October 1, 2023.
- This is the American ICD-10-CM version of C49.8 – other international versions of ICD-10 C49.8 may differ.
Applicable To
- Primary malignant neoplasm of two or more contiguous sites of connective and soft tissue
The following code(s) above C49.8 contain annotation back-references
that may be applicable to C49.8:
Approximate Synonyms
- Angiosarcoma, overlapping sites
- Cancer of the soft tissue, overlapping sites
- Leiomyosarcoma, overlapping sites
- Liposarcoma, overlapping sites
- Malignant fibrous histiocytoma, overlapping sites
- Overlapping malignant neoplasm of soft tissues
- Overlapping primary angiosarcoma
- Overlapping primary leiomyosarcoma
- Overlapping primary liposarcoma
- Overlapping primary malignant fibrous histiocytoma
- Overlapping primary rhabdomyosarcoma
- Overlapping primary sarcoma
- Rhabdomyosarcoma, overlapping sites
- Sarcoma, overlapping sites
ICD-10-CM C49.8 is grouped within Diagnostic Related Group(s) (MS-DRG v41.0):
- 542 Pathological fractures and musculoskeletal and connective tissue malignancy with mcc
- 543 Pathological fractures and musculoskeletal and connective tissue malignancy with cc
- 544 Pathological fractures and musculoskeletal and connective tissue malignancy without cc/mcc
Convert C49.8 to ICD-9-CMCode History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
- 2024 (effective 10/1/2023): No change